Structure Therapeutics Inc. (NASDAQ: GPCR) reported Q3 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Structure Therapeutics Inc. (GPCR) click here.